english.prescrire.org > Annual Prescrire Awards > The Prescrire Awards for 2024 > Prescrire Drug Awards for 2024 > Prescrire Drug Awards for 2024

The Prescrire Awards for 2024

Prescrire Drug Awards for 2024

The Prescrire Drug Awards for 2024

Every month, Prescrire's Editorial Staff help health professionals decide which of the multitude of newly authorised products or indications are worth adding to their list of useful treatment options, and which are to be avoided. We do this by conducting systematic analyses of the relevant evaluation data available on new drugs, new indications, new pharmaceutical forms and new dose strengths authorised in Europe or in France.

Le Palmarès des Médicaments
  • Fexinidazole Winthrop° was awarded the 2024 Pilule d'Or in recognition of the major therapeutic advance it represents in the treatment of a neglected disease.

Bicafres°, sodium bicarbonate gastro-resistant tablets, has been granted marketing authorisation in France, where, previously, oral sodium bicarbonate was only available as an extemporaneous preparation. It earned the title of "Noteworthy" drug in recognition of this marketing authorisation procedure, which guarantees the quality of a cheap and useful drug.

 


Download the full article:

Télécharger
 FREE  "The Prescrire Awards for 2024" Prescrire Int 2025; 34 (270): 136-139. FREE.

 

Back to "The Prescrire Awards for 2024"

©Prescrire May 2025      

Filet

Enjoy full access to Prescrire International, and support independent medical information